Unit 1: Biosafety

Biosafety is the discipline of containment principles, technologies and practices that prevent unintentional exposure to biological agents or their accidental release. It rests on matching the hazard of an agent to a set of engineering, procedural and personal safeguards, so that laboratory work never exceeds the protection built around it.

• Core aim: Protect the worker, the community and the environment from pathogenic microorganisms, toxins and recombinant materials.
• Risk group (RG): Classification of agents (RG1–RG4) by pathogenicity, transmissibility, availability of prophylaxis and host range; drives the choice of containment.
• Three pillars: Laboratory practice and technique (the most important), safety equipment (primary barriers), and facility design (secondary barriers).
• Containment types: Primary protects personnel and the immediate area (cabinets, PPE); secondary protects the outside environment (facility construction, ventilation).
• Governing bodies: WHO Laboratory Biosafety Manual, US CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), and NIH Guidelines for recombinant DNA.

II. Introduction

Scope and vocabulary of biosafety as a working framework.

A. Definition and objectives

Biosafety converts an assessed risk into a defined level of protection.

• Biohazard: Any biological material capable of causing harm — infectious bacteria, viruses, fungi, parasites, prions, toxins and allergens.
• Exposure routes: Inhalation of aerosols, ingestion, percutaneous inoculation (needlestick, sharps), and contact with mucous membranes or broken skin.
• Aerosol emphasis: Most laboratory-acquired infections arise from inhaled aerosols generated by pipetting, centrifuging, vortexing and sonication, so aerosol control drives design.

B. Biosecurity versus biosafety

The two terms are paired but distinct.

1. Biosafety: Prevents accidental release or exposure through containment and technique.
2. Biosecurity: Prevents deliberate theft, misuse or diversion of agents through access control, inventory and personnel reliability.

III. Historical Background

How documented laboratory infections shaped modern containment.

A. Development of the field

Biosafety grew empirically from tracking infections among laboratory staff.

• Early recognition (1900s–1940s): Reports of typhoid, brucellosis and tularemia in laboratory workers established that lab work itself was hazardous.
• Arnold Wedum (1943 onward): Director of safety at Camp Detrick (US biological research), he pioneered aerosol studies and cabinet design and is regarded as a founder of the discipline.
• Sulkin and Pike surveys (1949–1976): Compiled thousands of laboratory-acquired infections, showing that fewer than 20% were linked to a known accident — implicating unnoticed aerosols.
• Class II cabinet (1960s): Development of the HEPA-filtered, laminar-flow cabinet allowed both product and personnel protection.
• Asilomar Conference (1975): Scientists set voluntary containment guidelines for recombinant DNA, leading directly to the NIH Guidelines (1976).
• BMBL (1984): CDC/NIH published the codified biosafety-level system now used internationally.

IV. Biological Safety Cabinets

The principal primary barrier against aerosols.

A. Purpose and principle

A biological safety cabinet (BSC) is a ventilated enclosure that captures aerosols using directional airflow and HEPA filtration.

• HEPA filter: Removes ≥99.97% of particles at 0.3 µm, the most-penetrating particle size; cleans exhaust and, in Class II, the air bathing the work surface.
• Distinction from fume hood: A chemical fume hood protects only the user and does not filter biohazards; a BSC is not a substitute for a fume hood with volatile chemicals unless specifically vented.

B. Class I

Provides personnel and environmental protection but not product protection.

• Airflow: Room air is drawn inward across the work opening (≈0.38 m/s face velocity) and exhausted through a HEPA filter.
• Limitation: Unfiltered inflow passes over the sample, so it cannot protect sterile cultures from contamination.

C. Class II

The most common cabinet, giving personnel, environmental and product protection.

• Mechanism: A downward laminar sheet of HEPA-filtered air protects the sample while an inflow air curtain at the opening protects the worker; both streams draw into the front grille.
• Types A2, B1, B2: Differ by the proportion of air recirculated versus exhausted and whether they are hard-ducted, which governs use with trace volatile chemicals.

D. Class III

A fully sealed, gas-tight glovebox for the highest-risk agents.

• Design: Work performed through attached rubber gloves; supply air is HEPA-filtered and exhaust passes through two HEPA filters in series.
• Use: Mandatory maximum containment (BSL-4) glovebox line for agents such as those causing viral hemorrhagic fevers.

V. Containment for Biohazards

The barrier system that keeps agents where they belong.

A. Primary containment

Protects personnel and the immediate laboratory environment.

• Equipment: Biological safety cabinets, sealed centrifuge rotors and safety cups, and personal protective equipment (gloves, gowns, respirators).
• Vaccination: Immunization of at-risk staff acts as a supporting primary safeguard where a vaccine exists.

B. Secondary containment

Protects the environment external to the laboratory.

• Facility features: Controlled access, hand-washing sinks, autoclaves for waste decontamination, and directional inward airflow.
• High-level additions: Sealed penetrations, HEPA-filtered exhaust, effluent decontamination and airlocked entry at higher levels.

C. Biological risk assessment

Selecting containment begins by rating the agent and the procedure.

• Agent factors: Risk group, infectious dose, stability, route of transmission and available treatment.
• Procedure factors: Concentration and volume handled, and whether the work generates aerosols; higher risk shifts the required level upward.

VI. Biosafety Levels

The four graded combinations of practice, equipment and facility.

A. Framework

Each biosafety level (BSL) stacks additional safeguards onto the level below it.

• BSL-1: For well-characterized agents not known to cause disease in healthy adults (e.g., non-pathogenic E. coli K-12, Bacillus subtilis).
  • Practices: Standard microbiological technique, open bench, hand-washing, no eating; PPE limited to gloves and coat.
• BSL-2: For moderate-hazard agents transmitted by ingestion or percutaneous/mucosal exposure (e.g., Staphylococcus aureus, Salmonella, hepatitis B).
  • Practices: Restricted access, biohazard signage, sharps precautions; a Class II BSC used for aerosol-generating steps.
• BSL-3: For indigenous or exotic agents causing serious disease by inhalation (e.g., Mycobacterium tuberculosis, Bacillus anthracis, SARS-CoV-2).
  • Facility: Double self-closing doors, directional inward airflow, non-recirculated HEPA-filtered exhaust; all work in a BSC with respiratory protection.
• BSL-4: For dangerous, often untreatable agents with high aerosol-transmission risk (e.g., Ebola, Marburg, Lassa viruses).
  • Facility: Isolated building or zone, Class III cabinet line or positive-pressure suit, airlocks, chemical shower exit and effluent decontamination.

VII. Biosafety Levels of Specific Microorganisms

Assigning agents to a level by their properties.

A. Basis of assignment

The recommended level follows from the agent's risk group and route of transmission, not its taxonomy alone.

• Bacteria: Lactobacillus (BSL-1); Salmonella typhi, Vibrio cholerae (BSL-2); Mycobacterium tuberculosis, Yersinia pestis, Brucella (BSL-3).
• Viruses: Adenovirus vectors, hepatitis B/C, HIV (BSL-2 for clinical volumes); Highly pathogenic avian influenza (BSL-3); hemorrhagic-fever viruses (BSL-4).
• Fungi: Candida albicans (BSL-2); Coccidioides immitis and Histoplasma capsulatum in mold form (BSL-3, high aerosol infectivity).
• Parasites: Plasmodium, Toxoplasma gondii, Leishmania (BSL-2).

B. Modifying conditions

The same agent may shift level with the work being done.

• Volume and concentration: Large-scale or high-titre production of a BSL-2 agent may require BSL-3 practices.
• Aerosol-generating steps: Work that creates aerosols raises the equipment requirement even when the base assignment is lower.

VIII. Recommended Biosafety Levels for Infectious Agents and Infected Animals

Extending the framework to procedures and to work with animals.

A. Agent-based recommendations

Published agent summaries pair each pathogen with a level and specific precautions.

• Agent summary statements: The BMBL lists each agent with its recommended BSL, principal hazards and any vaccine or special containment note.
• Special precautions: Sharps handling for bloodborne agents, respiratory protection for inhalation hazards, and immunization where available.

B. Animal Biosafety Levels (ABSL)

Working with infected animals adds hazards absent from the bench, so a parallel ABSL-1 to ABSL-4 scale applies.

• Added hazards: Bites and scratches, contaminated bedding and dander aerosols, and shedding of agent in urine, feces or saliva.
• ABSL-1: Animals with agents not known to cause human disease; standard husbandry.
• ABSL-2: Moderate-hazard agents; limited access, PPE, BSC for aerosol procedures such as necropsy and inoculation.
• ABSL-3: Agents causing serious disease by inhalation; sealed, directional-airflow animal rooms with HEPA-filtered exhaust and respiratory protection.
• ABSL-4: Dangerous exotic agents; maximum-containment animal facility with suit or Class III systems.

C. Arthropod containment

Vector work carries the extra risk of escape of infected insects.

• Physical control: Cold rooms, escape traps, moats and double-door insectaries to recapture escapees.
• Recording: Continuous accounting of arthropods so that any loss is detected and managed.

D. Significance and limitations

The graded system succeeds only where practice keeps pace with design.

• Strength: Standardized, layered protection lets comparable work proceed safely across institutions.
• Limitation: Engineering cannot offset poor technique; most incidents trace to human error, so training, audit and a strong safety culture remain decisive.